STOCK TITAN

Precigen (PGEN) CFO receives 120,000 RSUs and options on 399,000 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Precigen, Inc.’s Chief Financial Officer Harry Thomasian Jr. reported compensation-related equity grants. He received 120,000 Restricted Stock Units, each representing one share of Precigen common stock, and options on 399,000 shares of common stock at an exercise price of $4.11 per share.

The options vest 25% on May 23, 2027, then in equal monthly installments for three years. The RSUs vest 25% on May 23, 2027, then in equal six‑month installments for three years. The filing shows no open‑market purchases or sales, only awards granted.

Positive

  • None.

Negative

  • None.
Insider Thomasian Harry Jr.
Role Chief Financial Officer
Type Security Shares Price Value
Grant/Award Option to Purchase Common Stock (Right to Buy) 399,000 $0.00 --
Grant/Award Restricted Stock Units 120,000 $0.00 --
Holdings After Transaction: Option to Purchase Common Stock (Right to Buy) — 399,000 shares (Direct, null); Restricted Stock Units — 120,000 shares (Direct, null)
Footnotes (1)
  1. The options vest 25% on May 23, 2027 and in equal monthly installments for three years thereafter. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. The RSUs vest 25% on May 23, 2027 and in equal six-month installments for three years thereafter.
RSU grant 120,000 units Restricted Stock Units representing common stock awarded to CFO
Option grant size 399,000 options Options to purchase common stock awarded to CFO
Option exercise price $4.11 per share Strike price for options to purchase Precigen common stock
Option expiration April 20, 2036 Expiration date of the granted stock options
RSUs following transaction 120,000 units Total RSUs held from this award after the transaction
Options following transaction 399,000 options Total options held from this award after the transaction
Initial vesting date May 23, 2027 Start of vesting for both options and RSUs
Restricted Stock Units financial
"security_title: "Restricted Stock Units""
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
exercise price financial
"conversion_or_exercise_price: "4.1100" per share for the options"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-04-20T00:00:00.000Z" for the options grant"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"The options vest 25% on May 23, 2027 and monthly thereafter"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
underlying security financial
"underlying_security_title: "Common Stock" for both awards"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Thomasian Harry Jr.

(Last)(First)(Middle)
20374 SENECA MEADOWS PARKWAY

(Street)
GERMANTOWN MARYLAND 20876

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
PRECIGEN, INC. [ PGEN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/20/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Option to Purchase Common Stock (Right to Buy)$4.1104/20/2026A399,000 (1)04/20/2036Common Stock399,000$0399,000D
Restricted Stock Units(2)04/20/2026A120,000 (3) (3)Common Stock120,000$0120,000D
Explanation of Responses:
1. The options vest 25% on May 23, 2027 and in equal monthly installments for three years thereafter.
2. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
3. The RSUs vest 25% on May 23, 2027 and in equal six-month installments for three years thereafter.
/s/ Harry Thomasian, Jr., by Donald P. Lehr, as attorney-in-fact04/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What equity awards did Precigen (PGEN) grant its CFO in this Form 4?

Precigen granted CFO Harry Thomasian Jr. 120,000 Restricted Stock Units and options to purchase 399,000 shares of common stock. These awards are part of his compensation and provide potential future ownership if vesting and, for options, exercise conditions are met.

What is the exercise price and term of the new Precigen (PGEN) stock options?

The options granted to the CFO carry an exercise price of $4.11 per share and expire on April 20, 2036. They give him the right, but not the obligation, to buy Precigen common shares at this price once vested.

How do the new Precigen (PGEN) options and RSUs vest over time?

Both awards start vesting on May 23, 2027. Options vest 25% on that date, then in equal monthly installments over three additional years. RSUs vest 25% on that date, then in equal six‑month installments across the same three‑year period.

Did the Precigen (PGEN) CFO buy or sell shares on the open market in this filing?

No open‑market buying or selling occurred. The Form 4 reports compensation grants: Restricted Stock Units and stock options awarded at no cash cost, rather than market purchases or sales. It reflects equity-based pay, not discretionary trading activity.

What are the CFO’s holdings from these newly reported Precigen (PGEN) awards?

Following the reported transactions, the CFO holds 120,000 Restricted Stock Units and options for 399,000 underlying common shares from these grants. Actual share delivery depends on vesting and, for options, his choice to exercise at the stated price.